NCT06742801 - Onyx™ Liquid Embolic IDE Clinical Study | Biotech Hunter

Enrollment

119

Participants

Timeline

Start Date

May 9, 2025

Primary Completion Date

November 30, 2026

Study Completion Date

December 31, 2026

Conditions

Peripheral Arterial HemorrhageTraumaGI BleedUlcerHemorrhage

Interventions

DEVICE

Onyx™ Liquid Embolic System

The proposed indication for Onyx™ LES is: Onyx™ LES is indicated for the embolization of arterial hemorrhage in the peripheral vasculature.

Trial Locations (9)

RECRUITING

The Mount Sinai, New York

RECRUITING

Albany Medical Center, Albany

RECRUITING

The Ohio State University, Columbus

RECRUITING

CHI Health Creighton University Medical Center-Bergan-Mercy, Omaha

RECRUITING

UCHealth University of Colorado Hospital, Aurora

RECRUITING

University of California, Irvine, Irvine

RECRUITING

Stanford Medical Center, Palo Alto

RECRUITING

Yale New Haven, New Haven

SUSPENDED

Masschusetts General Hospital, Boston